R
REGULUS THERAPEUTICS INC
NASDAQ: RGLS (Regulus Therapeutics Inc.)
最近更新时间: 8小时之前7.87
0.02 (0.25%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Regulus Therapeutics Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.1
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.13 |
|
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 2.18% |
| 机构持股比例 | 86.69% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Federated Hermes, Inc. | 31 Mar 2025 | 15,819,863 |
| Octagon Capital Advisors Lp | 31 Mar 2025 | 4,637,076 |
| Deep Track Capital, Lp | 31 Mar 2025 | 3,262,564 |
| Baker Bros. Advisors Lp | 31 Mar 2025 | 2,694,044 |
| Point72 Asset Management, L.P. | 31 Mar 2025 | 1,968,293 |
| Driehaus Capital Management Llc | 31 Mar 2025 | 958,345 |
| Alyeska Investment Group, L.P. | 31 Mar 2025 | 937,500 |
| Dafna Capital Management Llc | 31 Mar 2025 | 847,176 |
| Sphera Funds Management Ltd. | 31 Mar 2025 | 452,845 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 11.00 (Canaccord Genuity, 39.77%) | 保留 |
| 中 | 9.00 (14.36%) | |
| 低 | 7.00 (Jones Trading, -11.06%) | 保留 |
| 7.00 (Leerink Partners, -11.06%) | 保留 | |
| 平均值 | 8.80 (11.82%) | |
| 总计 | 1 购买, 4 保留 | |
| 平均价格@调整类型 | 6.65 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 01 May 2025 | 9.00 (14.36%) | 保留 | 7.85 |
| 27 Mar 2025 | 6.00 (-23.76%) | 购买 | 1.50 | |
| Canaccord Genuity | 30 Apr 2025 | 11.00 (39.77%) | 保留 | 7.98 |
| 17 Mar 2025 | 28.00 (255.78%) | 购买 | 1.37 | |
| Jones Trading | 30 Apr 2025 | 7.00 (-11.05%) | 保留 | 7.98 |
| Leerink Partners | 30 Apr 2025 | 7.00 (-11.05%) | 保留 | 7.98 |
| HC Wainwright & Co. | 14 Mar 2025 | 10.00 (27.06%) | 购买 | 1.48 |
| 26 Feb 2025 | 10.00 (27.06%) | 购买 | 1.36 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合